NPI Details
DR. Henning Helmut Schade, M.D. is an internal medicine in Denver, CO with 19 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. DR. Henning Helmut Schade, M.D. NPI is 1104112515. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
The provider's business location address is:
1721 E 19TH AVE STE 300
DENVER, CO
ZIP 80218-258
Phone: (720) 754-4800
Fax: (720) 754-4801
The NPI 1104112515 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS:J9144)
- Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
- Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
- Insertion of needle into vein for collection of blood sample (HCPCS:36415)
- Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
- Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
- Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
- Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
- Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
- Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
- Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
- Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
- Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
- Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
- Injection of additional new drug or substance into vein (HCPCS:96375)
- Infusion into a vein for hydration, each additional hour (HCPCS:96361)
- Injection of drug or substance under skin or into muscle (HCPCS:96372)
- Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
- New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
- Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:Q0221)
- Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
- Hospital discharge day management, more than 30 minutes (HCPCS:99239)
- Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
- Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
- Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:Q0220)
The enumeration date for this NPI number is 6/23/2011 and was last updated on 7/20/2016.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
| No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
| 1 | 207R00000X | Internal Medicine | | LL33771 | SOUTH CAROLINA | No |
| 2 | 207R00000X | Internal Medicine | | 56526 | COLORADO | Yes |
Other Identifiers
The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.
| No. |
Other Provider Identifier |
Other Provider Identifier Type |
Other Provider Identifier State |
Other Provider Identifier Issuer |
| 1 | 512114YWUP | MEDICARE PIN | COLORADO | |
